FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2577642912> ?p ?o ?g. }

• W2577642912 endingPage "813" @default.
• W2577642912 startingPage "802" @default.
• W2577642912 abstract "Essentials Specialized proresolving mediators (SPMs) promote the resolution of inflammation. This study sought to investigate the effects of SPMs on human platelet function. The SPM, Maresin 1, enhanced hemostatic, but suppressed inflammatory functions of platelets. SPMs uniquely regulate platelet function and may represent a new class of antiplatelet agents.Background Antiplatelet therapy is a cornerstone of modern medical practice and is routinely employed to reduce the likelihood of myocardial infarction, thrombosis and stroke. However, current antiplatelet therapies, such as aspirin, often have adverse side-effects, including increased risk of bleeding, and some patients are relatively 'aspirin-resistant'. Platelets are intimately involved in hemostasis and inflammation, and clinical consequences are associated with excessive or insufficient platelet activation. Objectives A major unmet need in the field of hematology is the development of new agents that safely prevent unwanted platelet activation in patients with underlying cardiovascular disease, while minimizing the risk of bleeding. Here, we investigate the potential of endogenously produced, specialized pro-resolving mediators (SPMs) as novel antiplatelet agents. SPMs are a recently discovered class of lipid-derived molecules that drive the resolution of inflammation without being overtly immunosuppressive. Methods Human platelets were treated with lipoxin A4, resolvin D1, resolvin D2, 17-HDHA or maresin 1 for 15 min, then were subjected to platelet function tests, including spreading, aggregation and inflammatory mediator release. Results We show for the first time that human platelets express the SPM receptors, GPR32 and ALX. Furthermore, our data demonstrate that maresin 1 differentially regulates platelet hemostatic function by enhancing platelet aggregation and spreading, while suppressing release of proinflammatory and prothrombotic mediators. Conclusions These data support the concept that SPMs differentially regulate platelet function and may represent a novel class of antiplatelet agents. SPMs also may play an important role in the resolution of inflammation in cardiovascular diseases." @default.
• W2577642912 created "2017-01-26" @default.
• W2577642912 creator A5037022435 @default.
• W2577642912 creator A5060123979 @default.
• W2577642912 creator A5064982745 @default.
• W2577642912 creator A5077271220 @default.
• W2577642912 date "2017-04-01" @default.
• W2577642912 modified "2023-10-15" @default.
• W2577642912 title "Maresin 1 induces a novel pro‐resolving phenotype in human platelets" @default.
• W2577642912 cites W1531140346 @default.
• W2577642912 cites W1935610350 @default.
• W2577642912 cites W1943114074 @default.
• W2577642912 cites W1968096525 @default.
• W2577642912 cites W1978134672 @default.
• W2577642912 cites W1979004719 @default.
• W2577642912 cites W1986229742 @default.
• W2577642912 cites W1987449056 @default.
• W2577642912 cites W1990341278 @default.
• W2577642912 cites W2003968006 @default.
• W2577642912 cites W2004536682 @default.
• W2577642912 cites W2016046934 @default.
• W2577642912 cites W2018885051 @default.
• W2577642912 cites W2021065306 @default.
• W2577642912 cites W2047711788 @default.
• W2577642912 cites W2080485793 @default.
• W2577642912 cites W2093928471 @default.
• W2577642912 cites W2094236361 @default.
• W2577642912 cites W2100994932 @default.
• W2577642912 cites W2102138771 @default.
• W2577642912 cites W2103010344 @default.
• W2577642912 cites W2106363644 @default.
• W2577642912 cites W2120699390 @default.
• W2577642912 cites W2121365522 @default.
• W2577642912 cites W2127130381 @default.
• W2577642912 cites W2133210615 @default.
• W2577642912 cites W2134236498 @default.
• W2577642912 cites W2140210316 @default.
• W2577642912 cites W2148740884 @default.
• W2577642912 cites W2156416313 @default.
• W2577642912 cites W2159913536 @default.
• W2577642912 cites W2163137314 @default.
• W2577642912 cites W2171278791 @default.
• W2577642912 cites W2210741139 @default.
• W2577642912 cites W2272063300 @default.
• W2577642912 cites W2277194059 @default.
• W2577642912 cites W2284643044 @default.
• W2577642912 cites W2315516921 @default.
• W2577642912 cites W2443199170 @default.
• W2577642912 cites W98074226 @default.
• W2577642912 doi "https://doi.org/10.1111/jth.13620" @default.
• W2577642912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5378657" @default.
• W2577642912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28079976" @default.
• W2577642912 hasPublicationYear "2017" @default.
• W2577642912 type Work @default.
• W2577642912 sameAs 2577642912 @default.
• W2577642912 citedByCount "44" @default.
• W2577642912 countsByYear W25776429122017 @default.
• W2577642912 countsByYear W25776429122018 @default.
• W2577642912 countsByYear W25776429122019 @default.
• W2577642912 countsByYear W25776429122020 @default.
• W2577642912 countsByYear W25776429122021 @default.
• W2577642912 countsByYear W25776429122022 @default.
• W2577642912 countsByYear W25776429122023 @default.
• W2577642912 crossrefType "journal-article" @default.
• W2577642912 hasAuthorship W2577642912A5037022435 @default.
• W2577642912 hasAuthorship W2577642912A5060123979 @default.
• W2577642912 hasAuthorship W2577642912A5064982745 @default.
• W2577642912 hasAuthorship W2577642912A5077271220 @default.
• W2577642912 hasBestOaLocation W25776429121 @default.
• W2577642912 hasConcept C126322002 @default.
• W2577642912 hasConcept C180899940 @default.
• W2577642912 hasConcept C185592680 @default.
• W2577642912 hasConcept C203014093 @default.
• W2577642912 hasConcept C2107291 @default.
• W2577642912 hasConcept C2776914184 @default.
• W2577642912 hasConcept C2777628954 @default.
• W2577642912 hasConcept C2778589496 @default.
• W2577642912 hasConcept C3018697912 @default.
• W2577642912 hasConcept C71924100 @default.
• W2577642912 hasConcept C89560881 @default.
• W2577642912 hasConcept C98274493 @default.
• W2577642912 hasConceptScore W2577642912C126322002 @default.
• W2577642912 hasConceptScore W2577642912C180899940 @default.
• W2577642912 hasConceptScore W2577642912C185592680 @default.
• W2577642912 hasConceptScore W2577642912C203014093 @default.
• W2577642912 hasConceptScore W2577642912C2107291 @default.
• W2577642912 hasConceptScore W2577642912C2776914184 @default.
• W2577642912 hasConceptScore W2577642912C2777628954 @default.
• W2577642912 hasConceptScore W2577642912C2778589496 @default.
• W2577642912 hasConceptScore W2577642912C3018697912 @default.
• W2577642912 hasConceptScore W2577642912C71924100 @default.
• W2577642912 hasConceptScore W2577642912C89560881 @default.
• W2577642912 hasConceptScore W2577642912C98274493 @default.
• W2577642912 hasFunder F4320306082 @default.
• W2577642912 hasFunder F4320310246 @default.
• W2577642912 hasFunder F4320332161 @default.
• W2577642912 hasFunder F4320337375 @default.
• W2577642912 hasIssue "4" @default.

• next